Brief: Ampio Pharmaceuticals Issues Letter To Stockholders

Ampio Pharmaceuticals

03/08/2022 13:37

Aug 3 (Reuters) - Ampio Pharmaceuticals Inc  AMPE.A :
    * AMPIO PHARMACEUTICALS ISSUES LETTER TO STOCKHOLDERS
    * AMPIO PHARMA - SPECIAL COMMITTEE'S FINDINGS INCLUDE FORMER
AMPIO
EXECUTIVE OFFICERS, SENIOR STAFF DID NOT FULLY REPORT RESULTS OF
AP-013 TRIAL, TIMING OF UNBLINDING OF DATA FROM AP-013 TRIAL
    * AMPIO PHARMACEUTICALS - SPECIAL COMMITTEE HAS DETERMINED
THAT
COMPANY'S CURRENT EXECUTIVE OFFICERS WERE NOT MADE AWARE OF
UNBLINDING EVENTS IN MARCH 2020
    * AMPIO PHARMA- RELATED TO AMPION, SPECIAL COMMITTEE'S
PRIMARY
FINDING IS THAT SOME AMPIO PERSONNEL FACILITATED PROVISION OF
AMPION FOR UNAUTHORIZED USE
    * AMPIO PHARMA - SPECIAL COMMITTEE'S PRIMARY FINDINGS SAY
SOME
FORMER AMPIO EXECUTIVES WERE AWARE AP-013 TRIAL DIDN'T SHOW
EFFICACY FOR AMPION
    * AMPIO PHARMACEUTICALS INC - RESULTS OF SAFETY SURVEILLANCE
ACTIVITIES HAVE NOT CHANGED COMPANY'S VIEW OF SAFETY PROFILE OF
AMPION
    * AMPIO PHARMA - SPECIAL COMMITTEE HAS DETERMINED THAT
COMPANY'S
CURRENT EXECUTIVE OFFICERS WERE NOT INVOLVED IN PROVISION OF
AMPION FOR UNAUTHORIZED USE
    * AMPIO PHARMACEUTICALS INC - HAS TERMINATED EMPLOYMENT OF
TWO
EXECUTIVE OFFICERS
    * AMPIO PHARMACEUTICALS INC - RESTRUCTURED BOARD OF
DIRECTORS
THROUGH RESIGNATION OF CERTAIN DIRECTORS
    * AMPIO PHARMACEUTICALS INC - SEPARATED ROLE OF CHAIR OF
BOARD AND
CHIEF EXECUTIVE OFFICER
    * AMPIO PHARMACEUTICALS INC - CONDUCTED COMPANY-WIDE
TRAINING
REGARDING APPROPRIATE USE OF AMPION WHILE IN CLINICAL TRIAL
STAGE
    * AMPIO PHARMA -  SPECIAL COMMITTEE FINDS FORMER EXECUTIVES,
SENIOR STAFF DIDN'T FULLY REPORT RESULTS OF AP-013 TRIAL, TIMING
OF UNBLINDING OF DATA
    * AMPIO PHARMACEUTICALS INC - HAS DETERMINED THAT COMPANY'S
CURRENT EXECUTIVE OFFICERS WERE NOT INVOLVED IN PROVISION OF
AMPION FOR UNAUTHORIZED USE

Source text for Eikon:  ID:nPn7zBfgMa 
Further company coverage:  AMPE.A